Rossari Biotech (NSE:ROSSARI) ROCE %: 19.56% (As of Mar. 2026)


NSE:ROSSARI Rossari Biotech Ltd NSE:ROSSARI
85 GF Score
Price ₹534.85
GF Value ₹998.23
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Rossari Biotech ROCE %?

Rossari Biotech NSE:ROSSARI -0.48% 85 ROCE % is 19.56% as of Mar. 2026. GuruFocus rates NSE:ROSSARI with a GF Score™ of 85/100 and a GF Value™ of ₹998.23 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Rossari Biotech's annualized ROCE % for the quarter that ended in Mar. 2026 was 19.56%.

Rossari Biotech  (NSE:ROSSARI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Rossari Biotech ROCE % Related Terms

Rossari Biotech ROCE % Historical Data

* Premium members only.

The historical data trend for Rossari Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rossari Biotech ROCE % Chart

Rossari Biotech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only 21.69 16.81 18.19 16.19 16.16

Rossari Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.65 15.25 15.45 13.90 19.56
NSE:ROSSARI
85GF Score
Rossari Biotech Ltd NSE:ROSSARI
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rossari Biotech ROCE % Calculation

Rossari Biotech's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=2310.58/( ( (18961.84 - 5365.72) + (22887.92 - 7895.58) )/ 2 )
=2310.58/( (13596.12+14992.34)/ 2 )
=2310.58/14294.23
=16.16 %

Rossari Biotech's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=2932.08/( ( (0 - 0) + (22887.92 - 7895.58) )/ 1 )
=2932.08/( ( 0 + 14992.34 )/ 1 )
=2932.08/14992.34
=19.56 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 19.56% mean?
Rossari Biotech (NSE:ROSSARI) has a ROCE % of 19.56% as of Mar. 2026.
Is Rossari Biotech's ROCE % too high?
Rossari Biotech's current ROCE % is 19.56%. The Chemicals industry median ROCE % is 6.42. Rossari Biotech's value of 19.56% is 204.7% above this industry median. Overall, Rossari Biotech has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's ROCE % compare to LIN and SHW?
Rossari Biotech's ROCE % of 19.56% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.42. Rossari Biotech's value of 19.56% is 204.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Chemicals company?
The median ROCE % among Chemicals companies is 6.42, based on 1,595 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossari Biotech's current ROCE % of 19.56% is 204.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossari Biotech's current ROCE % is 19.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹998.23, compared to a current price of ₹534.85 — trading 46.4% below its estimated fair value. The current ROCE % is 19.56% and 204.7% above the Chemicals industry median of 6.42. Rossari Biotech's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current ROCE % is 19.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?

Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued. The current stock price of ₹534.85 is trading 46.4% below its estimated GF Value™ of ₹998.23. GuruFocus considers Rossari Biotech to be Possible Value Trap.

Key valuation signals for NSE:ROSSARI:

  • ROCE %: 19.56%
  • GF Value™: ₹998.23 vs. price of ₹534.85 (46.4% below fair value)
  • GF Score™: 85/100 with 4 warning signs
  • Industry Position: 204.7% above the Chemicals median

No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rossari Biotech Business Description

Other Exchanges 543213:India
Address Rossari House, Lal Bahadur Shastri Marg, Golden Oak, Opp. Mahindra Showroom, Vikhroli (West), Surya Nagar, Mumbai, MH, IND, 400079
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
85GF Score

Get the complete analysis for NSE:ROSSARI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹534.85
Price
₹998.23
GF Value